What is Upstream Bio, Inc.'s asset turnover?

Upstream Bio, Inc. (UPB) reported asset turnover of 0× in Q1 2026.

What does asset turnover mean?

Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Upstream Bio, Inc. UPB Asset turnover

Asset turnover at other companies

AmgenAMGN

0.4×0.0×

Regeneron PharmaceuticalsREGN

0.4×0.0×

Aclaris TherapeuticsACRS

0×-0.1×

Shattuck Labs, Inc.STTK

0×0.0×

AnaptysBio, Inc.ANAB

0.6×+0.3×

Avalo TherapeuticsAVTX

0×-0.1×

Other financials

Income statement

See full

Revenue$1.0M+82.7%

Operating income-$43.6M-36.2%

Net income-$40.6M-48.8%

EPS (diluted)-$0.75-47.1%

Balance sheet

See full

Cash & equivalents$96.7M+35.6%

Total debt$1.1M-34.5%

Total equity$304.0M-31.8%

Total assets$318.1M-30.3%

Cash flow

See full

Operating cash flow-$47.9M-16.2%

CapEx$54.0K-70.8%

Free cash flow-$30.7M-55.0%

Valuation

See full

Market cap$346.11M-40.9%

Enterprise value$250.5M-51.4%

P/S104.2×-151×

Profitability

See full

Operating margin-5,176.5%+1,764pp

Net margin-4,719%+2,752pp

Returns & leverage

See full

Return on equity-41.8%—

Debt / equity0×0.0×

Current ratio23.1×-24.3×

Where this comes from

Calculated from Upstream Bio, Inc.’s reported figures.

total revenue/total assets=0×

Based on trailing twelve months.

The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Upstream Bio, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Upstream Bio, Inc.'s asset turnover?: Upstream Bio, Inc. (UPB) reported asset turnover of 0× in Q1 2026.
What does asset turnover mean?: Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.